New England Peptide Names Antibody Project Manager


GARDNER, Mass., April 17, 2008 – New England Peptide, LLC (NEP), has named Kristin Byrne antibody project manager.

In this position, created to support NEP’s growth, Byrne will work directly with customers to provide antigen/sequence design support and advisory services. Her responsibilities will include antibody project management, bioinformatics related to antigen selection, conjugation of peptides to carrier protein, and other types of protein characterization/quantitation.

Byrne joins NEP from Quality Controlled Biochemicals (QCB) in Hopkinton, Mass., where she held the positions of immunology laboratory technician, antibody production specialist, and immunology department manager. During her tenure at QCB, she performed and managed a wide variety of tasks involved in antibody production, including preparing antigens and affinity purification resins, purifying antibodies from serum samples, and running immunological assays.

Her experience incorporates optimization of procedures through research and experimentation with protocols, quality control, and coordination of shipments and lab schedules. Bryne’s work has included a special focus on customer communication and trouble-shooting for custom projects.

Byrne holds a Bachelor of Science degree in biology from the University of Massachusetts. She now is working toward a Master of Science degree in biotechnology at Worcester State College.

The creation of the antibody manager position, described by Dave Robinson, CEO, as one of many growth positions the company has filled recently, demonstrates NEP’s commitment to grow its high-quality antibody program. “Kristin is the ideal individual to lead this effort,” he says, “as she shares NEP’s passion for service and industry leading results with a compelling blend of solid scientific expertise and bend-over-backwards customer service.”

New England Peptide (www.newenglandpeptide.com), founded in 1998, designs and produces custom peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, Mass., the company’s chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications.

Peptides are small proteins that play key roles in biochemical regulation of all life systems, helping to fight diseases as diverse as cancer, diabetes, obesity, and HIV/AIDS. Peptides’ inherent low toxicity and high potency, coupled with improved drug delivery methods and enhanced manufacturing capabilities, are fueling a surge in research and clinical use. All segments of the peptide market – from therapeutics and vaccines to diagnostics and cosmetics – are thriving.

#

Contact: Dave Robinson, New England Peptide, 978-630-0020, dave.robinson@newenglandpeptide.com

 

http://www.pharmalive.com/News/index.cfm?articleid=532399&categoryid=33,34 

Testimonials

"The phospho-NL-4 Ab is fantastic, so that is great news! We have a VERY exciting study ongoing with it.
Not sure if you saw but the original phospho NL-1 Ab you guys made for us we just published in Nature Neuroscience. Thanks for making great antibodies, and we look forward to keep working with you guys!"
Michael B. PhD – NIH